Daily BriefsECM

Daily Brief ECM: Trial Holdings IPO: Valuation Thoughts and more

In today’s briefing:

  • Trial Holdings IPO: Valuation Thoughts
  • Nippon Express Placement – Lukewarm Track Record, Although Buyback Could Lift Share Price
  • Chongho Bridge Pre-IPO Tearsheet
  • ECM Weekly (4th Mar 2024) – Tokyo Metro, Mixue, Xtalpi, Bharat InvIT, Renesas, ITC/BAT, Precinct


Trial Holdings IPO: Valuation Thoughts

By Arun George

  • Trial Holdings (5882 JP), a discount store operator in Japan, is seeking to raise US$236 million at the IPO reference price of JPY1,550 per share.
  • We previously discussed the IPO in Trial Holdings IPO: The Investment Case
  • In this note, we discuss valuation. Our analysis suggests that Trial is attractively valued at the IPO reference price of JPY1,550. We would participate in the IPO.

Nippon Express Placement – Lukewarm Track Record, Although Buyback Could Lift Share Price

By Clarence Chu

  • A group of shareholders are looking to raise US$220m from selling their stakes in Nippon Express Holdings (9147 JP).
  • Overall, the deal would be a relatively large one to digest at 11 days of Nippon Express’ three month ADV, and 4.8% of the firm’s total shares outstanding.
  • Together with the announcement, the firm has also guided towards a share buyback program which should provide some share price support a month post-deal,  in our view.

Chongho Bridge Pre-IPO Tearsheet

By Ethan Aw

  • Chongho Bridge (2314866D CH) is looking to raise up to US$500m in its upcoming HK IPO. The deal will be run by CICC.
  • Chongho Bridge (CB) is an integrated services provider to China’s rural population. It offers rural inclusive credit services, agricultural production services, rural consumer goods and rural clean energy services.  
  • According to F&S, CB is the largest non-traditional financial institution targeting China’s rural market in terms of total loan balance as of FY22 (31st Dec 22).

ECM Weekly (4th Mar 2024) – Tokyo Metro, Mixue, Xtalpi, Bharat InvIT, Renesas, ITC/BAT, Precinct

By Sumeet Singh


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars